Join Europe’s leading CGT investment community for exclusive access to startups, scaleups, and the scientists redefining advanced therapies. At Advanced Therapies Europe 2026, investors gain curated visibility, strategic insight, and unmatched deal-making potential — all in one place.
✅ 996 pre-arranged meetings.
✅ 171 Therapeutic Developers.
✅ Curated 1:1 partnering designed for outcomes.
Europe’s CGT market is entering a more disciplined phase. Capital is tighter, timelines are longer, and only the strongest assets are attracting sustained backing. The shift toward later-stage validation means investors must balance scientific promise with clear commercial pathways and reimbursement potential.
Explore how Advanced Therapies Europe empowers biotechs to accelerate their commercialisation journey. From engaging with investors at our exclusive Investor Summit on Day 1 to building valuable partnerships with industry leaders, every moment is designed to drive your success. Dive into the agenda, connect with peers, and meet solution providers ready to support your growth.
Start with macro and micro trends shaping CGT investment — from capital flows to platform-based valuations.
Biotech CEOs share real-world experiences in securing funding, navigating milestones, and scaling in complex markets.
High-quality deal flow - Access a curated pipeline of advanced therapy companies actively seeking capital. Spend less time filtering and more time engaging with credible, investment-ready prospects.
Understanding risk in Europe - Gain a clearer view of execution risk across manufacturing, reimbursement and regulation. Identify which models are scalable and which will struggle in Europe’s evolving landscape.
Direct access to decision-makers - Meet founders and CEOs in pre-qualified meetings. Move quickly from initial conversations to deeper diligence with the people driving strategy and execution.
Signals from pharma and regulators - Understand how partnering strategies and regulatory direction are evolving. These signals shape valuation, timelines and exit potential across advanced therapies.
Capital deployment with confidence - See where momentum is building and where bottlenecks remain. Position your portfolio with greater clarity in a market that rewards discipline and informed decision-making.
If you’re preparing for your next funding round, strategic partnership, or commercial milestone, this is where those conversations move forward. Designed for clinical-stage and scaling biotechs, Advanced Therapies Europe gives you direct access to the capital, partners, and insight needed to move from progress to execution.
If you’re looking to deploy capital into the most promising advanced therapies, this is where qualified deal flow converges. Advanced Therapies Europe connects you with clinical-stage and scaling biotechs actively preparing for their next inflection point.
The Delegate Pack helps you assess the quality of opportunity before you attend. Inside the delegate pack:
Who might you find on the show floor?
2025 Attendee List 2025 Exhibitor List
